Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Microbiology

Open Access

HilA-like regulators in Escherichia coli pathotypes: the YgeH protein from the enteroaggregative strain 042

  • Mário Hüttener1,
  • Manuela Dietrich1,
  • Sònia Paytubi2 and
  • Antonio Juárez1, 2Email author
BMC Microbiology201414:268

https://doi.org/10.1186/s12866-014-0268-5

Received: 2 June 2014

Accepted: 14 October 2014

Published: 25 October 2014

Abstract

Background

The HilA protein is the master regulator of the Salmonella pathogenicity island 1 (SPI1). EilA and YgeH proteins show a moderate similarity to HilA and are encoded in pathogenicity islands from several E. coli strains, both pathogenic and non-pathogenic. In the present work we characterize the YgeH protein from the enteroaggregative E. coli strain 042 (locus tag EC042_3050).

Results

We show that both E. coli 042 YgeH and EilA proteins are able to functionally replace HilA in Salmonella. Interestingly, this is not the rule for all YgeH proteins: the YgeH protein from the enterohaemorragic E. coli strain O157 appears to be non-functional. ygeH expression is not influenced by growth osmolarity or temperature, and moderately increases in cells entering the stationary phase. H-NS represses ygeH expression under all growth conditions tested, and binds with specificity to the ygeH promoter region. As expected, expression of ETT2 (Escherichia coli type 3 secretion system 2) genes requires YgeH: ETT2 operons are downregulated in a ygeH mutant. Accordingly, since H-NS represses ygeH expression, ETT2 expression is significantly increased in an hns mutant.

Conclusion

E. coli 042 YgeH protein is functional and able to replace HilA in Salmonella. ETT2 gene expression requires YgeH activity which, in turn, is subjected to H-NS silencing.

Keywords

HilAYgeHE. coli 042H-NS

Background

Diarrhoeal disease is the second leading cause of infant mortality under the age of 5 worldwide [1]. Enteropathogenic Escherichia coli (EPEC) is a human pathogen of the small intestine and is a significant cause of infantile diarrhea [2]. EPEC were recognized as pathogens several decades ago [3]. Later on, EPEC and enteroaggregative E. coli (EAEC) were distinguished from each other on the basis of their patterns of adherence to HEp-2 cells. Unlike the localised “microcolonyforming” pattern of adherence associated with EPEC, EAEC display a characteristic aggregative or “stacked-brick” pattern of adherence [4]. Nataro et al. demonstrated a significant association of EAEC with diarrhea in a case control study of children in Chile [4]. Immediately following the discovery of EAEC as a category of pathogenic E. coli, several epidemiological reports casted doubt on the pathogenic nature of EAEC [5]. Nevertheless, a volunteer study provided evidence for EAEC strain 042 eliciting diarrhea in the majority of volunteers [6]. Since then many studies have supported the association of EAEC and diarrhea in both developing countries and industrialized nations. Thus, EAEC have been significantly associated with (i) endemic diarrhea in infants in developing and industrialised nations, (ii) persistent diarrhea in HIV-positive patients, (iii) traveller’s diarrhea, (iv) food/ water-borne outbreaks, and (v) sporadic cases of diarrhea [6]. Furthermore, the increasing number of reports in which EAEC is implicated as the agent mediating diarrhea suggests that E. coli strains belonging to this pathotype are important emerging pathogens [7]. A large number of virulence factors has been associated with clinical illness in epidemiologic studies [8]. It is also remarkable that EAEC strains are heterogeneous [9]. As not all strains of EAEC tested elicited diarrhea, the EAEC strain 042 which caused diarrhea in the volunteer study became the prototypical EAEC strain for the study of virulence factors and EAEC pathogenicity [6]. Its genome has been sequenced [10] and the virulence factors characterized.

Success for a bacterial pathogen to cause disease requires not only the display of several virulence determinants, but also a precise control of their expression, such that each is expressed at the appropriate time and place in the host. A good example for that is expression of the Salmonella pathogenicity island 1 (SPI1). Several environmental factors and regulators have been identified as affecting SPI1 [11]. It has been shown that SPI1 environmental regulation converges in the modulation of the hilA gene [12]. hilA is located on SPI1 and encodes the HilA protein, a member of the OmpR/ToxR family of regulators [13],[14]. HilA regulation itself is very complex and responds to several stimuli [15]-[17]. Both positive and negative regulators dictate appropriate HilA levels, which, in turn, result in activation or repression of the SPI-encoded effectors.

A genomic analysis of the type 3 secretion system (TTSS) from E. coli showed that two different genomic islands encoded hilA homologues [18]. The eip island, identified in the E. coli 042 genome encodes, in addition to different effectors, the eilA gene, a HilA-like regulator [19]. In addition, the ETT2 pathogenicity island encodes the ygeH gene, which shows significant similarity to HilA. This latter pathogenicity island also encodes a TTSS and different effectors. Remarkably, whereas ETT2 appears to be functional in E. coli 042, it has been subjected in the rest of the strains analysed to varying degrees of mutational attrition that results in a non-functional TTSS.

The role of EilA, the HilA-homologue encoded in the genome of the enteroaggregative strain 042 was characterized a few years ago [19]. EilA expression was reported to modulate expression of different genes of the eip island (i.e., eipB, eipC, eipD, eicA and eaeX), as well as of two genes of a pathogenicity island not linked to eip (ETT2). EilA defect was associated to alterations in adherence to epithelial cells and to biofilm formation. A role for EilA modulating expression of the TTSS and effectors of different chromosomal islands in EAEC was suggested. In contrast to EilA, the regulatory role of YgeH has not been hitherto characterized. We study in this report YgeH. We show that it is able to compensate for HilA depletion in Salmonella. We also study its regulation, and describe some of its target genes in the ETT2 pathogenicity island from strain 042.

Methods

Bacterial strains, plasmids and culture conditions

All bacterial strains and plasmids used in this study are listed in Table 1. Cultures were normally grown in Luria-Bertani (LB) medium (10 g NaCl, 10 g tryptone and 5 g yeast extract per litre) at the indicated temperature with vigorous shaking at 200 r.p.m. (Innova 3100, New Brunswick Scientific). Where indicated, LB medium without NaCl (0 g per liter), or D-MEM supplemented 1:1 with LB together with added 0.2% glucose (eilA induction conditions described by [19]) was used. Antibiotics were used at the following concentrations: kanamycin (50 μg ml-1), carbenicillin (100 μg ml-1) and chloramphenicol (25 μg ml-1).
Table 1

Bacterial strains and plasmids used in this study

Strain or plasmid

Description

Source or reference(s)

S. enterica serovar Typhimurium

  

SV5015

SL1344 his+

J. Casades’s

MH-C1

SV5015 hilA::Cm

[20]

MHS-1

SV5015 ΔhilA

[20]

SV5258

SV5015 ΦinvF-lacZY

J. Casades’s

SV5258HilA

SV5258 ΔhilA::Cm

This work

MHS-2

SV5015 sipA::3XFLAG

This work

MHS-3

MHS-1 sipA::3XFLAG

This work

LB5000

rLT rSA rSB

[21]

Escherichia coli

  

E. coli O157:H7

does not produce either Shiga-like toxin I or II (ATCC N° 43888)

ATCC

AAG1

MG1655 ΔLacZYA

[22]

AAG1H

AAG1 Δhns

This work

AAG1IHFA

AAG1 ΔihfA::Cm

This work

AAG1IHFB

AAG1 ΔihfB::Cm

This work

AAG1HA

AAG1 Δhns ΔihfA::Cm

This work

AAG1HB

AAG1 Δhns ΔihfB::Cm

This work

AAG1ΔRSygeH

AAG1 ΔRSygeH integrated attB Kmr

This work

AAG1HΔRSygeH

AAG1H + λRSygeH

This work

AAG1HAλRSygeH

AAG1HA + λRSygeH

This work

AAG1HBλRSygeH

AAG1HB + λRSygeH

This work

EAEC 042

Cmr Smr Tcr

I. Henderson

042HNS

EAEC 042 hns

This work

042YgeH

EAEC 042 ygeH

This work

042YgeH3X

EAEC 042 ygeH::3xFLAG

This work

042YgeH3XHNS

042YgeH3X Δhns

This work

Plasmids

  

pKD4

bla FRT ahp FRT PS1 PS2 oriR6K Kmr Cbr

[23]

pKD3

bla FRT cat FRT PS1 PS2 oriR6K Cmr Cbr

[23]

pKD46

bla PBAD gam bet exo pSC101 oriTS Cbr

[23]

pCP20

bla cat cI 857 l PR flp pSC101 oriTS Cbr

[24]

pSUB11

3xFLAG- and Kmr-coding template vector

[25]

pBAD18

reppMB1 p araBAD Cbr

[26]

pBADHilA

pBAD18 + hilA SV5015

This work

pBADEilA

pBAD18 + eilA EAEC042

This work

pBADYgeH042

pBAD18 + ygeH EAEC042

This work

pBADYgeHO157

pBAD18 + ygeH O157:H7

This work

pRS551

Promoterless vector lacZ Kmr Cbr

[27]

pYgeH042

ygeH 042 promoter cloned into pRS551

This work

To construct plasmids pBADEilA, pBADYgeH042, pBADHilA and pBADYgeHO157, eilA and ygeH genes of strain E. coli 042, hilA gene of S. Typhimurium SL1344 strain and ygeH gene from E. coli O157H7 were amplified using oligonucleotides EILAKPNI5-EILAHINDIII3, YGEHKPNI5-YGEHHINDIII3, HILABADFW-HILABADRV and YGEHO157XbaFW-YGEHO157HindRV, respectively (see Additional file 1). The oligonucleotides add Kpn I and Hind III sites, to the eilA and ygeH genes from E. coli 042, Eco RI and Xba I sites to the hilA gene and Xba I - Hind III sites to ygeH gene from E. coli O157:H7. The corresponding Kpn I-Hind III, Eco RI-Xba I and Xba I-Hind III PCR fragments were cloned into pBAD18 digested with the same enzymes, resulting in plasmids pBADEilA, pBADYgeH042, pBADHilA and pBADYgeHO157, respectively.

Genetic manipulations

Standard molecular and genetic procedures were performed as described by [28]. Enzymes were used according to the manufacturer’s recommendations. Introduction of plasmids into Escherichia coli and S. Typhimurium strains was performed by electroporation of 10% glycerol-washed cells using an Eppendorf gene pulser (Electroporator 2510). Plasmids isolated from E. coli were first passaged through the restriction-deficient S. Typhimurium strain LB5000 [21] before transformation of S. Typhimurium SL1344 competent cells.

Chromosomal deletions of hilA from S. Typhimurium, hns, ihfA and ihfB from E. coli AAG1 and ygeH and hns from E. coli 042 were obtained by the λ Red recombinant method as previously described [23]. The antibiotic-resistance determinant of plasmid pKD4 was amplified using oligonucleotides HNSP1/HNSP2, YGEHP1/YGEHP2 for hns and ygeH genes, and, in the case of hilA, ihfA and ihfB deletions, the chloramphenicol resistance was amplified using as template the pKD3 plasmid and the oligonucleotides HIlAP1/HILAP2 and IHFAP1/IHFAP2, IHFBP1/IHFBP2 (see Additional file 1). Mutants were selected on LB plates containing the appropriate selection marker, and the successful deletion of the gene was confirmed by PCR using the primers CAT-C1 and CAT-C2 (chloramphenicol resistance; Cmr) or KT and K2 (kanamycin resistance; Kmr) in combination with specific primers located in the remaining gene sequence nearby (Additional file 1, P1UP/P2DOWN series oligonucleotides). When necessary, the antibiotic resistance was then eliminated by transforming the mutant strain with plasmid pCP20 and subsequent incubation at 43°C for two passages according to [23]. The double deletions were obtained by combining one previously deletion with other deletion associated with an antibiotic resistance.

Chromosomal insertions of 3XFLAG sequences to the sipA and ygeH genes were obtained by a modification of the λ Red recombinant method, as described by [25]. The antibiotic-resistance determinant of plasmid pSUB11 was amplified using oligonucleotides SIPA3XP1/SIPA3XP2 and YGEH3XP1/YGEH3XP2 for sipA and ygeH, respectively (Additional file 1). Mutants were selected on LB plates containing kanamycin, and successful 3XFLAG insertion was confirmed by PCR using the oligonucleotides KT and K2 (kanamycin resistance; Kmr) in combination with specific oligonucleotides located in the remaining gene sequence nearby (Additional file 1, 3XP1UP/3XP2DOWN series oligonucleotides). The SV5015SipA strain was used as a donor strain to transfer the SipA::3xFLAG fusion to strain SV5015HilA using phage P22 HT [29], generating strain SV5015SH. The chromosomal fusion YgeH::3xFLAG was constructed in the parental strain E. coli 042 and the isogenic mutant Δhns, generating 042YgeH3X and 042YgeH3XHNS strains, respectively.

Construction of an ygeH::lacZ transcriptional fusion

A transcriptional ygeH::lacZ fusion was constructed by cloning the promoter region of the ygeH gene from EAEC 042 into the pRS551 plasmid. A single copy of the fusion was then inserted into the chromosome of the AAG1 strain by using the bacteriophage λRS45 as described by [27]. First of all, the promoter region of the ygeH gene was amplified using the oligonucleotides YGEHBAMHI5/YGEHBAMHI3 (Additional file 1) that add a Bam HI site, and the resulting PCR product was purified using the kit High Pure PCR Product Purification Kit (Roche). Subsequently, the purified PCR product was digested with Bam HI enzyme (Fermentas) and ligated into the Bam HI-digested pRS551, generating the plasmid pYgeH. The transcriptional fusion ygeH::lacZ cloned into the plasmid pYgeH was then transferred to the λRS45 bacteriophage according to [27] and integrated as a single copy into the attB locus of the AAG1 chromosome. To confirm the correct insertion from the selected resulting colonies, a PCR screening was performed according to [30].

Beta-galactosidase assay

β-galactosidase activity measurements were performed as described by [31].

Cell-free supernatant preparation

The supernatants from cultures were obtained utilizing trichloroacetic acid (TCA) as agent for protein precipitation and acetone for removal traces from TCA treatment. The cultures were grown in LB medium until O.D.600nm at 2.0, and then 10 ml were centrifuged at 6.000 rpm for 10 minutes at room temperature. The supernatant was filtered with a 0.22 μm pore size filter (Millex GP, Millipore) and proteins were precipitated by adding TCA at a final concentration of 10% and maintaining samples on ice for 1 hour. The samples were then centrifuged for 30 minutes at 13.400 rpm at 4°C, the supernatants were discarded and 0.5 ml of acetone was added. The samples were centrifuged once more as described above. After removal of acetone the pellet was air-dried for 10 minutes and the samples were reconstituted in sample buffer (Laemmli sample buffer, Bio-Rad).

SDS-PAGE and western blotting

Protein samples were analysed by SDS-PAGE at 10% and 12.5%. Proteins were transferred from the gels to PVDF membranes. Western blot analysis was performed with monoclonal antibodies raised against FLAG-epitope (1:10.000, Sigma) or against GAPDH (1:2000, Thermo Scientific) and horseradish peroxidase-conjugated goat anti-mouse IgG (1:2500, Promega). Detection was performed by enhanced chemiluminescence using Quantity One software (Bio-Rad).

RNA isolation

Total RNA was extracted from bacteria using the RNeasy Mini kit (Qiagen) according to the manufacturer’s instruction. Potential traces of DNA were removed by digestion with DNase I (Turbo DNA-free, Ambion), according to the manufacturer’s protocol. RNA concentration and RNA quality were measured using a Nano- Drop 1000 (Thermo Fisher Scientific).

Real-time qRT-PCR

Real-time quantitative reverse transcription-PCR (qRT-PCR) was performed as previously described [32]. Briefly, 1 μg of total RNA was reverse transcribed to generate cDNA using the High-capacity cDNA Reverse Transcription kit (Applied Biosystems) as recommended by the manufacturer. As a control, parallel samples were run in which reverse transcriptase was omitted from the reaction mixture. Oligonucleotides complementary to the genes of interest were designed using primer3 software. Real-time PCR using SYBR green PCR master mix (Applied Biosystems) was carried out on the ABI Prism 7700 sequence detection system (Applied Biosystems). After analysis of amplification plots with the ABI Prism sds software package, relative quantification of gene transcription was performed using the comparative threshold cycle (CT) method. The relative amount of target cDNA was normalized using the gapA gene as an internal reference standard.

Electrophoretic mobility shift assay (EMSA)

For EMSA, a 228 bp fragment corresponding to the promoter region of the ygeH operon (nucleotides -207 to +21) was amplified using oligonucleotides YGEHBAMHI5/YGEHBAMHI3 (Additional file 1). For each reaction, 50 ng DNA were mixed with increasing concentrations of the purified H-NS-His protein in binding buffer (250 mM HEPES, pH 7.4, 350 mM KCl, 5 mM EDTA, 5 mM DTT, 500 μg BSA ml-1, 25% glycerol). After incubation for 30 min at room temperature, 20 μl of samples were separated on 5% polyacrylamide/0.5 TBE gel. The bands were stained using ethidium bromide and visualized using Quantity One software (Bio-Rad). For competitive EMSA, the fragment corresponding to the ygeH promoter region DNA (50 ng) was mixed with a 3 fold excess of competitor DNA (hlyR[33]) in a final volume of 20 μl, using the same binding buffer as described above. Increasing concentrations of H-NS His were added as indicated, and the reaction was incubated at room temperature for 30 min. The samples were resolved, stained and visualized as described above. Purified H-NS His protein was obtained as described [34], and the hlyR DNA was obtained as described by [33].

Results

The invasion gene regulator coded by ygeH shares significant homology to EilA and HilA proteins

The complete genome sequence of E. coli 042 strain has led to the identification of two open reading frames encoding two proteins EilA (565 aminoacids) and YgeH (458 aminoacids) that exhibit similarity with the S. Typhimurium HilA protein (37% and 29% of similarity with HilA, respectively). In addition to the already reported EilA regulator [19], the putative invasion gene regulator YgeH shows a significant degree of conservation (Figure 1). Whereas EilA appears to be restricted to E. coli 042 and other enteroaggregative strains, YgeH is also present in other E. coli strains, such as K12, enterohemorrhagic O157:H7, enteroaggregative hemorrhagic O104:H4 and others [18]. In spite of the significant degree of identity at the amino acid level between HilA and YgeH, no information is available about its biological activity, neither regulatory role nor its targets. Thus, we decided to further characterize this latter protein from strain 042.
Figure 1

Alignment showing the amino acid degree of conservation between HilA-like proteins. Sequence alignment using T-Coffee algorithms (http://www.ebi.ac.uk/Tools/msa/tcoffee/) of the amino acid sequences of the EilA, HilA, YgeH042 and YgeHO157 proteins [Swiss-Prot: D3H2F7, E1WAC1, D3GSU9, Q8X6H5, respectively]. The different intensities of blue colours indicate the amino acid degree of conservation. The black boxes represent the consensus sequence resulting from the alignment.

EilA and YgeH proteins from E. coli strain 042 complement the HilA− phenotype in S. Typhimurim strain SV5015

We addressed first the question whether the YgeH proteins from strain 042 (YgeH042) and from strain O157 (YgeHO157) could be functionally equivalent to HilA. To test this, we first constructed a ΔhilA mutant of S. Typhimurium strain SV5015 (see Methods section). To monitor HilA activity we tested the expression of the sipA gene. The sipA gene is encoded in the sic/sip operon. The SipA effector is secreted by the type III secretion system encoded in the Salmonella pathogenicity island 1 (SPI1). Expression and translocation of SipA requires HilA activation of SPI1 operons [12],[35]. To detect SipA, a 3xFLAG was fused to its C-terminal end. For the complementation studies, eilA and ygeH genes from strain 042 and the ygeH gene from strain O157 were cloned in the expression vector pBAD18 [26]. Wild-type SV5015SipA (SipA::3xFLAG) and its ΔhilA derivative (SV5015 SipA::3xFLAG ΔhilA) were transformed with plasmids pBAD18, pBADHilA, pABDEilA, pBADYgeH042 and pBADYgeHO157. Cultures of the different transformants were grown in LB medium containing carbenicillin. Proteins present in the corresponding supernatants were analyzed by SDS-PAGE and Coomassie Brilliant Blue staining (Figure 2A). Moreover SipA::3xFLAG was immunodetected with anti-flag specific antibodies. As expected, SipA protein could only be detected in wt strain SV5015 SipA::3xFLAG, but not in the corresponding ΔhilA derivative (Figures 2C). Alternatively, cultures of these strains were grown in LB medium containing carbenicillin and 0.2% arabinose. Overexpression of EilA, YgeH042, and YgeHO157 upon arabinose induction was confirmed by qRT-PCR. Upon arabinose inducing conditions, plasmids pBADHilA, pBADEilA, and pBADYgeH042 complemented in trans the ΔhilA mutation (Figure 2B and D). Interestingly, plasmid pBADYgeHO157 does not complement ΔhilA. The amount of expressed SipA::3xFLAG was very similar in strains harbouring either pBADHilA, pBADEilA or pBADYgeH. Other effector proteins could also be detected in cells expressing any of the three HilA-like modulators (Figure 2B). These results provide evidence for E. coli strain 042 EilA or YgeH proteins being able to functionally replace HilA in Salmonella, but not for YgeHO157. It is noteworthy that, compared to YgeH042, YgeHO157 presents 22 amino acid substitutions, that might result in loss of protein function (see Discussion section).
Figure 2

The HilA-like proteins EilA and YgeH from EAEC 042 are both able to complement in trans the ΔHilA phenotype in S. Typhimurium. Panel A and B: SDS-PAGE 10% from whole secreted protein from strains MHS-2 (SV5015 sipA::3xFLAG) and MHS-3 (sipA::3xFLAG hilA) stained with Coomassie brilliant blue. C and D: Western blots from whole secreted protein from strains MHS-2 and MHS-3. A and C: Samples obtained from cultures grown in LB medium. B and D: Samples obtained from cultures grown in LB 0.2% L-arabinose. The SipA::3xFLAG protein was detected using monoclonal anti-flag antibody. The asterisks indicate the expression of other effector proteins according to [36], which are also activated by HilA-like proteins.

EilA and YgeH042 activate sipA expression via InvF in Salmonella

The regulatory cascade leading to sipA expression requires HilA-mediated activation of InvF which, in turn, activates SipA [36]. To check if either EilA or YgeH042 would influence sipA expression by activating InvF, strain SV5258 (invF::lacZ ) was used. A ΔhilA derivative was constructed by transducing the ΔhilA::Cm allele from strain MH-C1. Strain SV5258 was transformed with plasmid pBAD18, and strain SV5258hilA was transformed with plasmids pABD18, pBADHilA, pBADEilA and pBADYgeH042. The corresponding transformants were grown at 37°C to the beginning of the stationary phase (OD600 2.0) either in LB medium or in LB medium containing 0.02% arabinose. As expected, neither arabinose nor the vector pBAD18 affected invF expression in the hilA + strain (Figure 3). In contrast, in ΔhilA mutant strain, the presence of plasmids pBADHilA, pBADEilA or pBADYgeH042 drastically increased invF transcription when cells were grown in LB medium containing arabinose (Figure 3). Hence, the effect of both EilA and YgeH042 influencing invF transcription is similar to that of HilA.
Figure 3

Expression of EilA and YgeH proteins induces invF expression. Transcription of invF in strains SV5258 and SV5258hilA was evaluated by measuring β-galactosidase activity in the different constructs. Samples were obtained from LB CB100 or LB CB100 L-arabinose 0.02% cultures at the beginning of stationary phase (O.D.600 of 2.0) at 37°C. Standard errors from three independent experiments are shown.

Regulation of ygeH042 expression

We recently shed light on the role of the nucleoid-associated proteins H-NS and Hha modulating hilA expression in Salmonella in a temperature-and growth phase-dependent manner. IHF appeared to antagonize H-NS-mediated repression of hilA when cells reach the stationary phase of growth [20]. We decided to study the growth conditions influencing ygeH 042 expression and the hypothetical role of the global modulator H-NS on ygeH 042 expression. We tried to construct a transcriptional ygeH::lacZ gene fusion in the chromosome of strain 042. Under our working conditions, it was not possible to obtain this fusion in the 042 chromosome. We therefore decided to construct it in strain AAG1 (a ΔlacZ derivative from strain MG1655). Expression studies were performed in wt cells and in cells lacking the modulators H-NS and/or IHF at varying temperatures and osmolarities, in exponentially growing cells as well as in cells entering the stationary phase. The most relevant regulatory transcriptional data obtained in strain AAG1 were thereafter validated in strain 042 by detecting YgeH::3xFLAG by qRT-PCR and Western Blotting, as well (see below).

The expression profile of ygeH 042 in different culture condition shows that stationary growth phase influences its expression, moderately increasing it. No effects of growth temperature or osmolarity are apparent (Figure 4A). With respect to the modulators H-NS and IHF, H-NS significantly represses ygeH 042 expression in the different conditions tested, including the onset of the stationary phase. IHF appears to be required for a proper expression of ygeH 042. The fact that deletion of either ihfA or ihfB only decreases ygeH 042 expression when the H-NS protein is available, suggest that, in the ygeH 042 regulatory region, IHF might antagonize H-NS (Figure 4B and C).
Figure 4

Effect of growth-phase, temperature, hns and ihf mutations on ygeH::lacZ expression. β-galactosidase activity of the ygeh::LacZ fusion was determined in E. coli strain AAG1 (A) and in different genetic backgrounds (B and C) grown under either different temperatures or growth media. Samples were obtained at the log and the onset of the stationary growth phases (O.D.600 of 0.4 and 2.0, respectively). Standard errors from three independent experiments are shown.

To confirm that the observed regulatory effect of H-NS on ygeH 042 expression in strain AGG1 also takes place in strain 042, ygeH 042 transcription was detected in strains 042 and 042Δhns by both real-time qRT-PCR and YgeH protein immunodetection. qRT-PCR shows an upregulation in the Δhns mutant of the +4.5 ± 0.17 compared to wt strain. To detect YgeH042, 3xFLAG was fused to its C-terminal end. The YgeH::3xFLAG was immunodectected by using the monoclonal anti-flag antibody. As expected from the results obtained in strain AAG1, expression of ygeH 042 increased in the absence of H-NS (Figure 5).
Figure 5

The H-NS protein represses the ygeH gene at 37°C in strain 042. Immunodetection of YgeH::3xFLAG in strains 042YgeH3X (YgeH::3xFLAG) and its isogenic mutant derivate 042YgeH3XHNS (YgeH::3XFLAG Δhns). Cultures were grown in LB medium at 37°C and samples were respectively collected at the logarithmic and onset of the stationary phase (OD600 of 0.4 and 2.0). Whole cell lysates (5 μg) were resolved by 12.5% SDS-PAGE. The YgeH::3xFLAG protein was detected using the monoclonal anti-FLAG antibody. The GapdH protein was used as a protein loading control in western blot analysis and was detected using the monoclonal anti-GapdH antibody. The values shown under the strain name represent the relative amount of protein found in the mutant strains as compared to the wt strain (set as 1).

We studied next if H-NS binds with specificity to ygeH 042 regulatory region. A virtual footprinting analysis of this region showed that it includes three putative sequences, predicted to be H-NS binding sites (see Additional file 2). A 228 bp DNA fragment that includes the ygeH 042 promoter region was used for EMSA assays. According to the transcriptional data, binding of H-NS could be shown for the selected DNA fragment (Figure 6A). To provide evidence for specificity of binding, a competitive band shift experiment was performed, using both the fragment corresponding to the ygeH 042 regulatory region, and a DNA fragment, corresponding to the regulatory region of the hly operon (407 bp). H-NS does not show specific binding to this fragment [33]. The competitive band shift assay showed that H-NS preferentially binds to the ygeH 042 regulatory region (Figure 6B).
Figure 6

H-NS-His protein binds to the ygeH regulatory region. Panel A: EMSA using a 228 bp fragment corresponding to the ygeH operon promoter region (nucleotides -207 to +21) and H-NS-His protein. 1) No protein, 2-8) increasing concentrations of H-NS-His (0.1, 0.2, 0.5, 1, 1.5, 2 and 4 μM, respectively). Panel B: Competitive EMSA using the DNA fragments corresponding to the ygeH operon promoter region and an excess of 3 fold of the competitor DNA (hlyR), in the presence of increasing concentrations of H-NS. 1) No protein, 2-5) increasing concentrations of H-NS-His (1, 1.5, 2 and 4 μM, respectively).

YgeH upregulates ETT2 determinants

Taking into account that YgeH is encoded in the ETT2 island, we decided to test the effect of YgeH depletion on expression of different ETT2 encoded genes. Genes selected corresponded to most of the ETT2-encoded operons, and were the eivF gene, encoding an InvF-like protein, eivA, etrA, eprH, ygeG, ygeK and yqeI (locus tag: EC042_3070, EC042_3060, EC042_3059, EC042_3049, EC042_3053, EC042_3045, respectively). Expression of these genes was first monitored by qRT-PCR in the wt 042 strain and in the ygeH 042 single mutant. As expected from YgeH being a transcriptional activator, depletion of ygeH resulted in downregulation of the different ETT2 genes (Figure 7A). Taking into account that ygeH expression is increased in an hns mutant, we decided to further investigate whether, as a response to reduced H-NS levels, ETT2 genes are also upregulated in a Δhns mutant. As expected, all the ETT2 genes tested are upregulated in strain 042 Δhns (Figure 7B). Hence, expression of ETT2 genetic determinants is subjected to H-NS-mediated repression via YgeH.
Figure 7

Effect of Δ ygeH and Δ hns mutations on the expression of ETT2 genes from EAEC 042. Expression of ETT2-related genes was determined by reverse transcription and qRT-PCR. Data show the transcription levels of ETT2-related genes in bacteria cultured in LB broth to early-stationary phase (O.D.600 of 2.0). As internal standard the gapA gene was used. Data are means of three independent experiments. Standard deviations are shown. Panel A: Relative expression of the ΔygeH mutant relative to wt strain. Panel B: Relative expression of the Δhns mutant compared to wt strain.

Discussion

In this report we provide evidence for the close relationship between the E. coli 042 YgeH protein, the EilA regulator and the Salmonella regulator HilA. Genomic studies have shown that the ETT2 island is widespread in Escherichia and Shigella strains [18],[37],[38], although in many of them the gene cluster is either disrupted or incomplete [18]. The YgeH protein, which shares significant similarity to the SPI1 modulator HilA, is present in several of the strains analyzed as, for instance, 042, O157:H7 or MG1655. We show here that the YgeH protein is functional in strain 042. Furthermore, the YgeH protein, as well as the already characterized EilA protein, is able to complement the ΔhilA mutation in Salmonella. All of them target the SPI1 gene invF which, in turn, activates the expression of effectors such as SipA. These results support the close functional and structural relationship between these proteins and suggest a common origin. Remarkably, whereas either YgeH042 or EilA complement the hilA mutation, YgeHO157 does not. The amino acid sequence of YgeH042 and of YgeHO157 differs in several amino acid residues, and these differences may be underlying loss of protein function.

Unlike eilA gene [19], ygeH is expressed when 042 cells grow in LB medium. Unlike hilA, significant expression levels are detected both at the exponential and stationary growth phases. Only a moderate increase in transcription is apparent at the onset of the stationary phase. When growing in LB medium, neither temperature nor osmolarity are critical factors altering ygeH 042 expression. Remarkably, H-NS appears as a repressor of ygeH 042 expression. Under all growth conditions tested, the hns mutant from strain 042 showed an upregulated expression of ygeH. Whereas these data show that H-NS is a repressor of ygeH 042 , it is also apparent that environmental conditions leading to a full induction of ygeH 042 (i.e., environmental conditions which would result in similar expression levels of ygeH 042 in both wt 042 strain and the hns mutant) are not among those used in this work. H-NS targeting ygeH 042 is also supported by the EMSA assays in the presence of a DNA fragment including the ygeH regulatory region and a competitor DNA molecule. Altogether, these data show that, when coping with the appropriate environmental conditions, 042 cells must be able to significantly increase YgeH levels by counteracting H-NS silencing.

A question to be addressed is the biological role of the either complete or incomplete ETT2 determinants in different E. coli isolates, ranging from MG1655 to O157:H7. Some previous data together with the results presented in this paper may help to clarify this. In a previous report [39], ygeH, etrA and eivF genes from the ETT2 genetic element from E. coli O157:H7 were mutagenized, and the effect of the corresponding mutant alleles on expression of the LEE (locus of enterocyte effacement) pathogenicity island was studied. Whereas disruption of the ygeH O157 gene did not influence LEE expression (and hence it was not further characterized), the etrA and eivF mutant alleles were found to significantly enhance secretion of proteins encoded by the LEE. Transcription of several LEE genes was altered in these mutants. We show in this report that, unlike YgeH042, YgeHO157 fails to complement the ΔhilA mutation. The production of a non-functional YgeH protein in E. coli strain O157 may be underlying the fact that, whereas etrA and eivF mutants of strain O157 influence LEE expression, ygeH mutants do not [39]. Hence, mutational attrition that occurs in some genomic islands may also affect some of the encoded modulators, thus resulting in a complex array of functional and non-functional genes that may significantly increase the genomic plasticity of those strains that incorporate the corresponding genomic islands.

Conclusions

YgeH and EilA proteins can functionally replace HilA in Salmonella. E. coli 042 YgeH protein expression is similar when cells grow in a wide variety of lab culture conditions. Whereas YgeH expression upregulates expression of ETT2 genes, H-NS downregulates their expression. As exemplified by YgeHO157 protein, some of the YgeH modulators encoded in ETT2 islands may be non-functional. Hence, mutational attrition identified in the ETT2 cluster is not restricted to YgeH-modulated genes, but may also affect the modulator itself.

Authors’ contributions

Conceived and designed the experiments: MH and AJ. Performed the experiments: MH, MD, SP. Analysed the data: MH, MD, SP and AJ. Wrote the manuscript: MH and AJ. All authors read and approved the final manuscript.

Additional files

Abbreviations

SPI1: 

Salmonella pathogenicity island 1

TTSS: 

Type 3 secretion system

ETT2: 

Escherichia coli type 3 secretion system 2

LEE: 

Locus of enterocyte effacement

Km: 

Kanamycin

CB: 

Carbenicillin

Cm: 

Choramphenicol

Sm: 

Streptomycin

Tc: 

Tetracycline

TCA: 

Trichloroacetic acid

Declarations

Acknowledgements

This work was supported by funds from the Spanish MICINN-FEDER (BFU2010-21836-C02-01 and CSD2008-00013) and the Generalitat de Catalunya (2009SGR66). We thank Prof. Josep Casades’s (University of Seville) and Prof. Ian Henderson (University of Birmingham) for providing strains.

Authors’ Affiliations

(1)
Institute for Bioengineering of Catalonia (IBEC)
(2)
Department of Microbiology, Faculty of Biology, University of Barcelona

References

  1. Wardlaw T, Salama P, Brocklehurst C, Chopra M, Mason E: Diarrhoea: why children are still dying and what can be done. Lancet. 2010, 375: 870-872. 10.1016/S0140-6736(09)61798-0.View ArticlePubMedGoogle Scholar
  2. Ruchaud-Sparagano M-H, Maresca M, Kenny B: Enteropathogenic Escherichia coli (EPEC) inactivate innate immune responses prior to compromising epithelial barrier function. Cell Microbiol. 2007, 9: 1909-1921. 10.1111/j.1462-5822.2007.00923.x.PubMed CentralView ArticlePubMedGoogle Scholar
  3. Kaper JB, Nataro JP, Mobley HL: Pathogenic Escherichia coli. Nat Rev Microbiol. 2004, 2: 123-140. 10.1038/nrmicro818.View ArticlePubMedGoogle Scholar
  4. Nataro JP, Kaper JB, Robins-Browne R, Prado V, Vial P, Levine MM: Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cells. Pediatr Infect Dis J. 1987, 6: 829-831. 10.1097/00006454-198709000-00008.View ArticlePubMedGoogle Scholar
  5. Harrington SM, Dudley EG, Nataro JP: Pathogenesis of enteroaggregative Escherichia coli infection. FEMS Microbiol Lett. 2006, 254: 12-18. 10.1111/j.1574-6968.2005.00005.x.View ArticlePubMedGoogle Scholar
  6. Nataro JP, Deng Y, Cookson S, Cravioto A, Savarino SJ, Guers LD, Levine MM, Tacket CO: Heterogeneity of enteroaggregative Escherichia coli virulence demonstrated in volunteers. J Infect Dis. 1995, 171: 465-468. 10.1093/infdis/171.2.465.View ArticlePubMedGoogle Scholar
  7. Huang DB, Nataro JP, DuPont HL, Kamat PP, Mhatre AD, Okhuysen PC, Chiang T: Enteroaggregative Escherichia coli is a cause of acute diarrheal illness: a meta-analysis. Clin Infect Dis. 2006, 43: 556-563. 10.1086/505869.View ArticlePubMedGoogle Scholar
  8. Estrada-Garcia T, Navarro-Garcia F: Enteroaggregative Escherichia coli pathotype: a genetically heterogeneous emerging foodborne enteropathogen. FEMS Immunol Med Microbiol. 2012, 66: 281-298. 10.1111/j.1574-695X.2012.01008.x.View ArticlePubMedGoogle Scholar
  9. Okeke IN, Wallace-Gadsden F, Simons HR, Matthews N, Labar AS, Hwang J, Wain J: Multi-locus sequence typing of enteroaggregative Escherichia coli isolates from Nigerian children uncovers multiple lineages. PLoS One. 2010, 5: e14093-10.1371/journal.pone.0014093.PubMed CentralView ArticlePubMedGoogle Scholar
  10. Chaudhuri RR, Sebaihia M, Hobman JL, Webber MA, Leyton DL, Goldberg MD, Cunningham AF, Scott-Tucker A, Ferguson PR, Thomas CM, Frankel G, Tang CM, Dudley EG, Roberts IS, Rasko DA, Pallen MJ, Parkhill J, Nataro JP, Thomson NR, Henderson IR: Complete genome sequence and comparative metabolic profiling of the prototypical enteroaggregative Escherichia coli strain 042. PLoS One. 2010, 5: e8801-10.1371/journal.pone.0008801.PubMed CentralView ArticlePubMedGoogle Scholar
  11. Altier C: Genetic and environmental control of salmonella invasion. J Microbiol. 2005, 43: 85-92.PubMedGoogle Scholar
  12. Ellermeier JR, Slauch JM: Adaptation to the host environment: regulation of the SPI1 type III secretion system in Salmonella enterica serovar Typhimurium. Curr Opin Microbiol. 2007, 10: 24-29. 10.1016/j.mib.2006.12.002.View ArticlePubMedGoogle Scholar
  13. Lee CA, Jones BD, Falkow S: Identification of a Salmonella typhimurium invasion locus by selection for hyperinvasive mutants. Proc Natl Acad Sci U S A. 1992, 89: 1847-1851. 10.1073/pnas.89.5.1847.PubMed CentralView ArticlePubMedGoogle Scholar
  14. Bajaj V, Hwang C, Lee CA: hilA is a novel ompR/toxR family member that activates the expression of Salmonella typhimurium invasion genes. Mol Microbiol. 1995, 18: 715-727. 10.1111/j.1365-2958.1995.mmi_18040715.x.View ArticlePubMedGoogle Scholar
  15. Jones BD, Falkow S: Identification and characterization of a Salmonella typhimurium oxygen-regulated gene required for bacterial internalization. Infect Immun. 1994, 62: 3745-3752.PubMed CentralPubMedGoogle Scholar
  16. Bajaj V, Lucas RL, Hwang C, Lee CA: Co-ordinate regulation of Salmonella typhimurium invasion genes by environmental and regulatory factors is mediated by control of hilA expression. Mol Microbiol. 1996, 22: 703-714. 10.1046/j.1365-2958.1996.d01-1718.x.View ArticlePubMedGoogle Scholar
  17. Chubiz JEC, Golubeva YA, Lin D, Miller LD, Slauch JM: FliZ regulates expression of the Salmonella pathogenicity island 1 invasion locus by controlling HilD protein activity in Salmonella enterica serovar typhimurium. J Bacteriol. 2010, 192: 6261-6270. 10.1128/JB.00635-10.PubMed CentralView ArticlePubMedGoogle Scholar
  18. Ren C-P, Chaudhuri RR, Fivian A, Bailey CM, Antonio M, Barnes WM, Pallen MJ: The ETT2 gene cluster, encoding a second type III secretion system from Escherichia coli, is present in the majority of strains but has undergone widespread mutational attrition. J Bacteriol. 2004, 186: 3547-3560. 10.1128/JB.186.11.3547-3560.2004.PubMed CentralView ArticlePubMedGoogle Scholar
  19. Sheikh J, Dudley EG, Sui B, Tamboura B, Suleman A, Nataro JP: EilA, a HilA-like regulator in enteroaggregative Escherichia coli. Mol Microbiol. 2006, 61: 338-350. 10.1111/j.1365-2958.2006.05234.x.View ArticlePubMedGoogle Scholar
  20. Queiroz MH, Madrid C, Paytubi S, Balsalobre C, Juárez A: Integration host factor alleviates H-NS silencing of the Salmonella enterica serovar Typhimurium master regulator of SPI1, hilA. Microbiol (Reading, Engl). 2011, 157: 2504-2514. 10.1099/mic.0.049197-0.View ArticleGoogle Scholar
  21. Bullas LR, Ryu JI: Salmonella typhimurium LT2 strains which are r- m + for all three chromosomally located systems of DNA restriction and modification. J Bacteriol. 1983, 156: 471-474.PubMed CentralPubMedGoogle Scholar
  22. Aberg A, Shingler V, Balsalobre C: Regulation of the fimB promoter: a case of differential regulation by ppGpp and DksA in vivo. Mol Microbiol. 2008, 67: 1223-1241. 10.1111/j.1365-2958.2008.06115.x.View ArticlePubMedGoogle Scholar
  23. Datsenko KA, Wanner BL: One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A. 2000, 97: 6640-6645. 10.1073/pnas.120163297.PubMed CentralView ArticlePubMedGoogle Scholar
  24. Cherepanov PP, Wackernagel W: Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene. 1995, 158: 9-14. 10.1016/0378-1119(95)00193-A.View ArticlePubMedGoogle Scholar
  25. Uzzau S, Figueroa-Bossi N, Rubino S, Bossi L: Epitope tagging of chromosomal genes in Salmonella. Proc Natl Acad Sci U S A. 2001, 98: 15264-15269. 10.1073/pnas.261348198.PubMed CentralView ArticlePubMedGoogle Scholar
  26. Guzman LM, Belin D, Carson MJ, Beckwith J: Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J Bacteriol. 1995, 177: 4121-4130.PubMed CentralPubMedGoogle Scholar
  27. Simons RW, Houman F, Kleckner N: Improved single and multicopy lac-based cloning vectors for protein and operon fusions. Gene. 1987, 53: 85-96. 10.1016/0378-1119(87)90095-3.View ArticlePubMedGoogle Scholar
  28. Sambrook J: Molecular Cloning: a Laboratory Manual, (3 Volume Set). 2001, Cold Spring Harbor Laboratory Press, Cold Spring Harbour, NYGoogle Scholar
  29. Schmieger H: Phage P22-mutants with increased or decreased transduction abilities. Mol Gen Genet. 1972, 119: 75-88. 10.1007/BF00270447.View ArticlePubMedGoogle Scholar
  30. Powell BS, Rivas MP, Court DL, Nakamura Y, Turnbough CL: Rapid confirmation of single copy lambda prophage integration by PCR. Nucleic Acids Res. 1994, 22: 5765-5766. 10.1093/nar/22.25.5765.PubMed CentralView ArticlePubMedGoogle Scholar
  31. Miller JH: A Short Course in Bacterial Genetics: a Laboratory Manual and Handbook for Escherichia Coli and Related Bacteria. 1992, Cold Spring Harbour Laboratory Press, Cold Spring Harbour NYGoogle Scholar
  32. Dietrich M, Mollenkopf H, So M, Friedrich A: Pilin regulation in the pilT mutant of Neisseria gonorrhoeae strain MS11. FEMS Microbiol Lett. 2009, 296: 248-256. 10.1111/j.1574-6968.2009.01647.x.PubMed CentralView ArticlePubMedGoogle Scholar
  33. Madrid C, Nieto JM, Paytubi S, Falconi M, Gualerzi CO, Juárez A: Temperature- and H-NS-dependent regulation of a plasmid-encoded virulence operon expressing Escherichia coli hemolysin. J Bacteriol. 2002, 184: 5058-5066. 10.1128/JB.184.18.5058-5066.2002.PubMed CentralView ArticlePubMedGoogle Scholar
  34. Nieto JM, Carmona M, Bolland S, Jubete Y, de La Cruz F, Juárez A: The hha gene modulates haemolysin expression in Escherichia coli. Mol Microbiol. 1991, 5: 1285-1293. 10.1111/j.1365-2958.1991.tb01902.x.View ArticlePubMedGoogle Scholar
  35. Lostroh CP, Bajaj V, Lee CA: The cis requirements for transcriptional activation by HilA, a virulence determinant encoded on SPI-1. Mol Microbiol. 2000, 37: 300-315. 10.1046/j.1365-2958.2000.01991.x.View ArticlePubMedGoogle Scholar
  36. Darwin KH, Miller VL: InvF is required for expression of genes encoding proteins secreted by the SPI1 type III secretion apparatus in Salmonella typhimurium. J Bacteriol. 1999, 181: 4949-4954.PubMedGoogle Scholar
  37. Makino S-I, Tobe T, Asakura H, Watarai M, Ikeda T, Takeshi K, Sasakawa C: Distribution of the secondary type III secretion system locus found in enterohemorrhagic Escherichia coli O157:H7 isolates among Shiga toxin-producing E. coli strains. J Clin Microbiol. 2003, 41: 2341-2347. 10.1128/JCM.41.6.2341-2347.2003.PubMed CentralView ArticlePubMedGoogle Scholar
  38. Osawa K, Shibata M, Nishiyama Y, Kurokawa M, Yamamoto G, Kinoshita S, Kataoka N: Identification of the ETT2 locus in human diarrheagenic Escherichia coli by multiplex PCR. J Infect Chemother. 2006, 12: 157-159. 10.1007/s10156-006-0435-1.View ArticlePubMedGoogle Scholar
  39. Zhang L, Chaudhuri RR, Constantinidou C, Hobman JL, Patel MD, Jones AC, Sarti D, Roe AJ, Vlisidou I, Shaw RK, Falciani F, Stevens MP, Gally DL, Knutton S, Frankel G, Penn CW, Pallen MJ: Regulators encoded in the Escherichia coli type III secretion system 2 gene cluster influence expression of genes within the locus for enterocyte effacement in enterohemorrhagic E. coli O157:H7. Infect Immun. 2004, 72: 7282-7293. 10.1128/IAI.72.12.7282-7293.2004.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© Hüttener et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement